An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers-Reference-Cited by-同舟云学术

An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers

Published:2021-08 Issue: Volume:175 Page:113795
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Xu Yining^ORCID,Shrestha Neha,Préat Véronique,Beloqui Ana^ORCID

Funder

European Research Council

FRS-FNRS

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference367 articles.

1. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers;Ensign;Adv. Drug Deliv. Rev.,2012

2. Sales of Oral Solid Dosage Pharmaceutical Formulation Market to Decelerate in 2020 as COVID-19 Pandemic Takes its Toll on Global Market, Future Market Insights, 2020.

3. In vitro and in vivo models for the study of oral delivery of nanoparticles;Gamboa;Adv. Drug Deliv. Rev.,2013

4. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems;Xu;J. Control. Release,2020

5. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues;Lundquist;Adv. Drug Deliv. Rev.,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of encapsulated flavors in food products; opportunities and challenges;Food Chemistry;2024-03

2. Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights;Journal of Biomolecular Structure and Dynamics;2024-02

3. Development and validation of UV–Vis spectrophotometric method for determination of rivastigmine in PBS and biological matrices: Application to ex vivo permeation profiles and in vivo studies from trilayer dissolving microneedle;Chemical Data Collections;2024-02

4. Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration;Pharmaceuticals;2024-01-30

5. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model;Pharmaceutics;2024-01-16